FTC approves Sun Pharma’s $4bn Ranbaxy merger

02-02-2015

FTC approves Sun Pharma’s $4bn Ranbaxy merger

Michael D Brown / Shutterstock.com

The US Federal Trade Commission (FTC) has given the green light for Sun Pharmaceutical to merge with Indian generic drug maker Ranbaxy for $4 billion.


FTC, Federal Trade Commission, Sun Pharmaceutical, Ranbaxy, M&A,

LSIPR